GT Biopharma Inc (GTBP): Be VERY Careful. OXIS watcher for 2+ yea...

Send PM Follow Ignore

Followers	12
Posts	609
Boards Moderated	0
Alias Born	04/20/2015

Gibba

Re: None

Tuesday, 04/04/2017 9:38:30 PM

Tuesday, April 04, 2017 9:38:30 PM

Be VERY Careful. OXIS watcher for 2+ years.

Charts Do not apply to OXIS. Heavy dilution coming. Pump and dump in my opinion, back to the the 01's by Friday.

IMO -

Keep Last Read

Replies (3) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent GTBP News

The $13 Million Company Teaching the Immune System to Hunt Cancer • PR Newswire (Canada) • 05/29/2026 01:00:00 PM
The $13 Million Company Teaching the Immune System to Hunt Cancer • PR Newswire (US) • 05/29/2026 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 12:00:37 PM
Three TriKE Candidates In Clinic As NK Cell Engager Field Reorganizes • PR Newswire (Canada) • 05/19/2026 01:00:00 PM
Three TriKE Candidates In Clinic As NK Cell Engager Field Reorganizes • PR Newswire (US) • 05/19/2026 01:00:00 PM
B7-H3 Becomes The Hottest Antigen In Oncology, And One NK Engager Enters Clinic • PR Newswire (Canada) • 05/18/2026 06:22:00 PM
B7-H3 Becomes The Hottest Antigen In Oncology, And One NK Engager Enters Clinic • PR Newswire (US) • 05/18/2026 06:22:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 12:00:50 PM
"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies • GlobeNewswire Inc. • 05/14/2026 02:55:00 PM
A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology • GlobeNewswire Inc. • 05/14/2026 01:15:00 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/14/2026 04:15:35 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/13/2026 09:18:43 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/30/2026 08:55:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 11:05:14 AM
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 03/06/2026 09:01:09 PM
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 03/06/2026 09:01:05 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 12:05:57 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 12:05:27 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/30/2026 10:12:20 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/21/2026 09:15:32 PM
5 Assets Securing the 2026 Material Cycle • GlobeNewswire Inc. • 01/16/2026 04:18:58 PM
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape • PR Newswire (US) • 01/16/2026 01:00:00 PM
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape • PR Newswire (Canada) • 01/16/2026 01:00:00 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/08/2026 09:19:06 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent GTBP News

More GTBP News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent GTBP News

Go Ad-Free